Role of Radiation Therapy for Newly Diagnosed Retroperitoneal Sarcoma

• Published in: Current treatment options in oncology 2021-09, Vol.22 (9), p.75-75, Article 75
• Main Authors: Lam, Miranda B., Baldini, Elizabeth H., Reijers, Sophie J. M., Haas, Rick L., DeLaney, Thomas F.
• Format: Article
• Language: English
• Subjects: Abdomen; Biopsy; Clinical Decision-Making; Combined Modality Therapy - adverse effects; Combined Modality Therapy - methods; Diagnostic Imaging; Disease Management; Gastric cancer; Humans; Liposarcoma; Medicine; Medicine & Public Health; Neoplasm Grading; Neoplasm Staging; Oncology; Patients; Prognosis; Radiation therapy; Radiotherapy - adverse effects; Radiotherapy - methods; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Retreatment; Retroperitoneal Neoplasms - diagnosis; Retroperitoneal Neoplasms - therapy; Sarcoma; Sarcoma (SH Okuno; Sarcoma - diagnosis; Sarcoma - therapy; Section Editor; Surgery; Survival; Time-to-Treatment; Topical Collection on Sarcoma; Treatment Outcome; Tumors
• ISSN: 1527-2729; 1534-6277; 1534-5277
• DOI: 10.1007/s11864-021-00877-6

Opinion statement Soft tissue sarcomas (STS) are rare, aggressive, and heterogenous tumors, comprising approximately 1% of adult cancers with over 50 different subtypes. The mainstay of treatment for retroperitoneal sarcomas (RPS) includes surgical resection. The addition of radiation therapy (RT), either preoperatively or postoperatively, has been used to potentially decrease the risk of local recurrence. The recently published results from STRASS (EORTC-STBSG 62092-22092), which randomized patients to receive or not receive preoperative radiation, indicate no abdominal recurrence-free survival benefit (primary endpoint) nor overall survival benefit to date from the addition of preoperative RT prior to surgical resection in patients with RPS. Keeping in mind caveats of subgroup analyses, the data show a significant reduction in local recurrence with radiation therapy in resected patients and non-significant trends toward improved abdominal recurrence-free survival in all patients and improved local control and abdominal recurrence-free survival in patients with liposarcoma and low-grade sarcoma. Given the high rate of local failure with surgery alone, it is possible that higher RT dose and/or selective RT dose painting may improve outcomes. Prior to treatment, the authors encourage multidisciplinary review and discussion of management options at a sarcoma center for patients with RPS. Selective use of RT may be considered for patients at high risk of local recurrence.